Compound Summary
药名: | myricanol |
分子式: | C21H26O5 |
Smiles: | COC1=C2C=C(CCCCC(CCC3=CC2=C(C=C3)O)O)C(=C1OC)O |
成分: | HBIN036081 |
TCMID_id: | 15152 |
PubChem_id: | 5319978 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE002759/YEM-264 | Myrica rubra (Lour.)Sieb.et Zucc. | 杨梅根|杨梅 | 杨梅 | 云南民族药物志:第二卷 | 阿昌族/傣族/德昂族/景颇族/傈僳族/水族/彝族/壮族 | |
TCMBANKHE005866/YEM-264 | Myrica rubra|Myrica rubra (Lour.)Sieb.et Zucc. | 杨梅树皮|杨梅 | 杨梅 | 云南民族药物志:第二卷 | To rectify qi and dissipate stasis, eliminate damp, relieve pain./Dysentery, knocks and falls, eye screen, toothache, burns and scalds, malign scab and lai sore. | 阿昌族/傣族/德昂族/景颇族/傈僳族/水族/彝族/壮族 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
TCMBANKDI000026 | Obesity | disease | Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 31339170 |
TCMBANKDI000031 | Insulin Resistance | phenotype | Nutritional and Metabolic Diseases | 31339170 |
TCMBANKDI026758 | Muscular Atrophy | phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 30793539 |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE001149 | PPARGC1A | LEM6; PGC-1(alpha); PGC-1alpha; PGC-1v; PGC1; PGC1A; PPARGC1 | PPARG coactivator 1 alpha |
TCMBANKGE001182 | SIRT1 | SIR2; SIR2L1; SIR2alpha | sirtuin 1 |